New Diabetes Drug Approved for Once a Week Dosage

.

New Diabetes Drug Approved for Once a Week Dosage

It has been recently revealed in a report that the new proposal of Amylin Pharmaceutical company for a more convenient and novel type of diabetes drug has been approved by the Food and Drug Administration. This shall now give way for a new type of Type 2 diabetes drug, which can be conveniently registered to people merely once a week and this would be able to give the people a better control over their disease and they would be able to live life happily and without any fears.

The name of the drug is Byudereon and this will be able to provide help to people suffering from diabetes, only by being administered once a week. There is a competitor drug for the same being developed by Novo Nordisk medical firm, and the name of this drug is Victoza, which shall also be injected once a day.

It has also been rumored that the celebrity chef Paula Deen is going to be the ambassador for their drug, who has apparently recently been diagnosed of diabetes herself.

"Think for a moment how much easier their lives would be by taking a drug just once a week, a drug that offers solid glucose control, does not require glucose monitoring and comes with added benefit of weight loss", revealed David Kliff, publisher of Diabetic Investor.

There is need for the patients of the disease to stay focused on maintaining a healthy life, with good habits of food and exercise. This alone can let them lead a healthy and balanced life, with no types of physical problems ahead of them. People with diabetes need to restrict and control their eating habits, in order to maintain the balance.


Latest News

Cracknell supports tax on sugary drinks in the UK
Patients less likely to die with more nurses, study
Gasoline Prices Drop Further in the Midwest and West due to Oversupply
Deutsche Bank Executives Face a Tough Turnaround Plan as Investors Lose Confiden
Viacom Misses Earnings Expectations for the Fifth Straight Quarter; CEO Takes a
Walt Disney Co. Reports Greater Than Expected First Fiscal Quarter Profits
Lara Casalotti finds stem cell donor
Sending mentally ill people long distances must stop, panel
Zenefits CEO Leaves Over Compliance Issues COO Takes Over
Apollo Education Group will be Acquired by a Group of Private Investors
BOJ’s Negative Interest Rate Expected to have Major Influence on Japan’s Banks
21st Century Fox Lowers Full Year Earnings Guidance